1 - Building the business eco-system for local production |
“Long-term government commitment and support for local production are critical to ensure sustained human capital development, financing, regulatory system strengthening and compliance with international quality standards, among others.” |
“With public health as the driver, policies among different ministries should be coherent with shared goals to promote local production and benefit public health needs.” |
“A concerted effort based on multi-stakeholder collaboration, with government support, is critical for market information to be available and accessible for sustainable local production.” |
2 - Getting regulatory systems for a pandemic ready |
“A strong regulatory system is an important component of the business ecosystem of local production.” |
“Local production and local regulatory capacity should be concomitantly strengthened, as local production without quality assurance does not deliver public health benefits.” |
“Regulatory harmonization and reliance through collaboration and cooperation can help regulatory authorities use limited resources effectively and reduce duplicative regulatory processes.” |
“Communication, information sharing and strengthening of networks are critical to agile regulatory systems and pandemic preparedness.” |
3 - Unlocking global manufacturing potential through licensing and technology transfer |
“Sharing of intellectual property, know-how, trade secrets, etc. and voluntary licensing and effective technology transfer are essential to facilitate rapid scale-up of production capacity.” |
“An enabling environment for technology transfer includes good governance, skilled workforce, access to market information, and viable national/regional markets, among others.” |
“The capacity to receive and absorb the transferred technology should be assessed to produce quality-assured products and to support a sound business plan.” |
4 - Expanding access to affordable capital |
“Governments need to elevate the importance of the public health agenda and public health security to enable supportive policies to promote a conducive financial environment.” |
“Strong, viable and bankable business cases, which offer long-term commercial sustainability and address local/regional health needs, are crucial to attract financing and investment.” |
“Cooperation and coordination among development banks, donors and other finance providers are essential to share risks.” |
5 - Building capacity to enhance access to vaccines and biologic products for COVID-19 and beyond |
“Technology, product and location diversification is important for pandemic scenario readiness and sustainability; the hub and spoke model could deliver high impact to the diversification with efficiency and address manufacturers’ training needs and skills development.” |
“Development of skilled human capital is a vital component. Skills and capacity building for manufacturers and regulators are needed to ensure quality and timely market entry. Training in particular areas includes technology transfer, GMP, process development, etc.” |
“Innovative technologies could potentially reduce the time and cost for establishing vaccine manufacturing. It could also generate production flexibility across vaccines and biologics and support long-term commercial viability and sustained capacity.” |
6 - Leveraging innovation, AI and the digital revolution in the health products industry |
“Innovation can take place in technology, product development, manufacturing processes and business models.” |
“Lower-middle-income countries can leverage on innovation and the digital revolution to strengthen capacity and deliver significant impacts on the production and distribution of health products.” |
“Innovations in artificial intelligence and the digital revolution can address specific challenges faced by lower-middle-income countries related to improving quality, reducing the risk and cost of drug development, data management, analysis and sharing, production, supply chains.” |